Stock Price Quote

OXYGENTA PHARMACEUTICAL LTD.

NSE : NABSE : 524636ISIN CODE : INE102E01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE41.481.97 (+4.99 %)
PREV CLOSE ( ) 39.51
OPEN PRICE ( ) 41.48
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15367
TODAY'S LOW / HIGH ( )41.48 41.48
52 WK LOW / HIGH ( ) 25.0252.27
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-11 1990
Management Info
- Chairman Sai Sudhakar Vankineni - Managing Director
Registered Office

Address Survey No. 252/1,Aroor Village,Sadasivapet Mandal,
Sangareddy,
Telangana-502291

Phone 08455-250080 / 25080

Email info@oxygentapharma.com / cs@oxygentapharma.com

Website www.oxygentapharma.com

Registrars Details
Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing : BSE

NEWS

08Apr Allotment of Equity Shares
Preferential Issue of shares Inter-alia, considered and approved the fo..
08Apr Open Offer
Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted..
03Apr Allotment of Equity Shares
Inter-alia, to consider and approve: 1. Raising of funds by way of issu..
30Mar Oxygenta Pharmaceutical informs about
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regu..
26Mar Clarification On Intimation Of Appoin
We are giving clarification for the mail received from exchange on 23rd..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-37.75-115.7
Gross Profit -35.45 -113.72
Operating Profit -24.42-70.99
Net Sales 91.78309.87

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  6660.85 (7.79%)
M.Cap ( in Cr)8545.80
Concord Biotech (BSE)
peergroup  1561.65 (3.68%)
M.Cap ( in Cr)16337.39
Sanofi India (BSE)
peergroup  8490.90 (0.51%)
M.Cap ( in Cr)19555.07
JB Chem & Pharma (BSE)
peergroup  1800.50 (2.37%)
M.Cap ( in Cr)27942.82
Divi's Lab (BSE)
peergroup  3779.20 (1.08%)
M.Cap ( in Cr)100325.89

Shareholding Pattern

NON-INSTITUTION 70.25%
PROMOTERS 29.73%
MUTUAL FUNDS/UTI 0.03%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd. was incorporated in the year 1990. Its today's share price is 41.48. Its current market capitalisation stands at Rs 138.89 Cr. In the latest quarter, company has reported Gross Sales of Rs. 309.87 Cr and Total Income of Rs.310.05 Cr. The company's management includes Sunel Vishram Chawda, Dolly Mandhan, Bharath Reddy Guntuku, Sravani Reddy Gantla, Raghavender Rao Kanuganti, Vidya Sagar Devabhutuni, Padmaja Surapureddy, Sanagari Kondal Reddy, Sai Sudhakar Vankineni.

It is listed on the BSE with a BSE Code of 524636 , NSE with an NSE Symbol of and ISIN of INE102E01018. It's Registered office is at Survey No. 252/1,Aroor Village,Sadasivapet MandalSangareddy-502291, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Gowri Shankar & Associates, VDNR & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.